D45: the decarbolyxation process for THC from a chemical perspective
Decarboxylation of THC and Other Cannabinoids: A Comprehensive Overview
Decarboxylation Fundamentals
Decarboxylation is the chemical reaction that transforms inactive cannabinoids like THCA (Tetrahydrocannabinolic Acid) into their active forms, such as THC. This is achieved through the removal of a carboxyl group (COOH) from the molecule.
Chemical Reaction of Decarboxylation:
For THCA to THC:
THCA —-> THC CO2
This process is facilitated by the application of heat, and in some cases, extended time.
Factors Affecting Decarboxylation
Uniformity of Heat Application
Uniform heating is crucial for efficient and consistent decarboxylation. Non-uniform heating can result in partial conversion and uneven potency (Eichner & Spindle, 2020).
Boiling Points
Different cannabinoids and other compounds have unique boiling points. Proper temperature control is essential to avoid losing valuable compounds (Hazekamp et al., 2016).
Heat Type
The source of heat (conduction, convection, etc.) can affect the speed and efficiency of the decarboxylation process. Convection is generally more uniform but may require specialized equipment.
Decarboxylation of Other Cannabinoids
Just like THCA can be decarboxylated to THC, other cannabinoids can also be activated:
CBDA to CBD
CBGA to CBG
THCVA to THCV
Comparison Table for Decarboxylation Parameters
Compound
Temperature (°C)
Duration (Minutes)
Heat Type
THCA
110-130
30-45
Convection
CBDA
110-130
45-60
Convection
CBGA
120-140
15-30
Conduction
THCVA
130-145
30-45
Convection
Advisory Note
Individuals with certain medical conditions like cardiovascular disorders, liver or kidney diseases, or psychiatric conditions may benefit from individually-guided cannabis care, and should exercise care when proceeding without supervision. Consultation with Dr. Caplan at CED Clinic is recommended for specialized, evidence-based care.
References
McGilveray, I. J. (2005). Pharmacokinetics of cannabinoids. Pain Research and Management, 10(Suppl A), 15A-22A.
Eichner, M., & Spindle, T. R. (2020). Cannabinoids: Pharmacology and Toxicology. In Cannabis sativa L. – Botany and Biotechnology (pp. 327-366). Springer.
Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006). Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Sciences, 95(6), 1308-1317.
Veress, T., Szallasi, A., & Blumberg, P. M. (1990). A sensitive method for the quantitive determination of capsaicinoids in natural extracts and pharmaceutical preparations by reversed-phase high performance liquid chromatography. Journal of Chromatography, 533, 293-299.
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360.
Contact Dr. Caplan at CED Clinic for specialized guidance, particularly if you have any of the mentioned medical conditions. Dr. Caplan offers expert advice based on individual medical histories and needs.
📗 Note: Enjoyed the diagram? It’s just the cherry on top. The full sundae is “The Doctor-Approved Cannabis Handbook.” Scoop it up here 📗.
Unlock the world of medical cannabis with The Doctor-Approved Cannabis Handbook.
